Sharad Chandrika, MD
Pulmonary Disease · Goodyear, AZNPI 1336153634
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,438 of the $10,558 with a category attached, or 61.0%. 27 manufacturers reported payments, led by Johnson & Johnson at 33.6% of the total. Reporting peaked in 2023 at $3,858 and has fallen 60.2% since, to $1,534 in 2025.
Across 110 payments — averaging $95.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$4K
- Noah Medical Corporation$3K
- Intuitive Surgical$2K
- Boston Scientific$1K
- Olympus America Inc.$308
- AstraZeneca$282
- plus $1K from 21 others
What the payments were for
- Travel & lodging$6,43861%
- Food & beverage$4,12039%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(3 entities) | 48 | $3,549 |
| Noah Medical Corporation | 7 | $2,641 |
| Intuitive Surgical | 11 | $1,566 |
| Boston Scientific | 6 | $1,071 |
| Olympus America Inc. | 3 | $308 |
| AstraZeneca(2 entities) | 4 | $282 |
| Sanofi | 2 | $261 |
| Covidien LP | 2 | $171 |
| Veran Medical Technologies, Inc. | 2 | $110 |
| Siemens Medical Solutions USA, Inc. | 1 | $62 |
| Gilead | 3 | $59 |
| Lilly USA, LLC | 3 | $49 |
| Incyte Corporation | 2 | $46 |
| Eisai Inc. | 2 | $42 |
| Puma Biotechnology, Inc. | 2 | $36 |
| Boehringer Ingelheim | 1 | $33 |
| Pulmonx Corporation | 1 | $31 |
| Myovant Sciences Inc. | 1 | $31 |
| Blueprint Medicines Corporation | 1 | $29 |
| Nuvation Bio Inc. | 1 | $28 |
| Olympus Corporation Of The Americas | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Merck | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Beigene USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monarch Platform$2,268
- Da Vinci Surgical System$1,493
- GALAXY$920
- GENERAL - THERAPIES$913
- SPiN Vision Video Processor$144
- Spiration Valve System$141
- DUPIXENT$140
- FASENRA$125
- IMFINZI$116
- Spin$101
How this compares
$10,558 in reported general payments places this provider in the 75th percentile of 250 pulmonary disease providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Goodyear
- George ParidesMesa$913K
- Rajat WaliaPhoenix$748K
- Abhinav MittalTucson$570K
- Brian PorvinPhoenix$276K
- Abid KhokarPhoenix$262K
- Tony HodgesPhoenix$248K
- Richard SueGilbert$224K
- Mark GotfriedPhoenix$196K
- Rajeev SaggarPhoenix$161K
- Gregory AhearnPhoenix$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.